Impact of preimplantation genetic testing for aneuploidies (PGT-A) on first trimester biochemical markers – PAPP-A (placenta-associated plasma protein) and free β-hCG (human chorionic gonadotropin)

References

• Kagan KO, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008;31(5):493–502.
   PubMed Web of Science ®Google Scholar
• Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod. 2001;16(7):1501–1504.
   PubMed Web of Science ®Google Scholar
• Hui PW, Lam YH, Tang MH, et al. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn. 2005;25(5):390–393.
   PubMed Web of Science ®Google Scholar
• Engels MA, Pajkrt E, Groot DT, et al. First trimester combined screening test in pregnancies derived from blastocyst transfer. Fetal Diagn Ther. 2013;34(4):217–224.
   PubMedGoogle Scholar
• Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn. 2002;22(8):718–721.
   PubMed Web of Science ®Google Scholar
• Gjerris AC, Loft A, Pinborg A, et al. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol. 2009;33(1):8–17.
   PubMed Web of Science ®Google Scholar
• Sermon K, Capalbo A, Cohen J, et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod. 2016;22(8):845–857.
   PubMed Web of Science ®Google Scholar
• de Sutter P, Stadhouders R, Dutre M, et al. Prevalence of chromosomal abnormalities and timing of karyotype analysis in patients with recurrent implantation failure (RIF) following assisted reproduction. Facts Views Vis Obgyn. 2012;4(1):59–65.
   PubMedGoogle Scholar
• Fragouli E, Wells D. Aneuploidy in the human blastocyst. Cytogenet Genome Res. 2011;133(2–4):149–159.
   PubMed Web of Science ®Google Scholar
• Munné S, Lee A, Rosenwaks Z, et al. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8(12):2185–2191.
   PubMed Web of Science ®Google Scholar
• Harper JC, Wilton L, Traeger-Synodinos J, et al. The ESHRE PGD consortium: 10 years of data collection. Hum Reprod Update. 2012;18(3):234–247.
   PubMed Web of Science ®Google Scholar
• Weissman A, Shoham G, Shoham Z, et al. Preimplantation genetic screening: results of a worldwide web-based survey. Reprod Biomed Online. 2017;35(6):693–700.
   PubMed Web of Science ®Google Scholar
• Scott RT Jr., Upham KM, Forman EJ, et al. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100(3):624–630.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304(6831):867–869.
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352(9125):343–346.
   PubMed Web of Science ®Google Scholar
• FETALMEDICINE.ORG. The 11–13 weeks scan; 2021. Available from: https://courses.fetalmedicine.com/fmf/
   Google Scholar
• Zhang S, Luo K, Cheng D, et al. Number of biopsied trophectoderm cells is likely to affect the implantation potential of blastocysts with poor trophectoderm quality. Fertil Steril. 2016;105(5):1222–1227.
   PubMed Web of Science ®Google Scholar
• Capalbo A, Wright G, Elliott T, et al. FISH reanalysis of inner cell mass and trophectoderm samples of previously array-CGH screened blastocysts shows high accuracy of diagnosis and no major diagnostic impact of mosaicism at the blastocyst stage. Hum Reprod. 2013;28(8):2298–2307.
   PubMed Web of Science ®Google Scholar
• Hjortebjerg R. IGFBP-4 and PAPP-A in normal physiology and disease. Growth Horm IGF Res. 2018;41:7–22.
   PubMed Web of Science ®Google Scholar
• Conover CA, Faessen GF, Ilg KE, et al. Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology. 2001;142(5):2155–2158.
   PubMed Web of Science ®Google Scholar
• Sifakis S, Androutsopoulos VP, Pontikaki A, et al. Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnancies is associated with FGR. Mol Med Rep. 2018;17(5):6435–6440.
   PubMed Web of Science ®Google Scholar
• Bellver J, Lara C, Soares SR, et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod. 2005;20(9):2623–2627.
   PubMed Web of Science ®Google Scholar
• Lu MM, Wen YX, Liu YL, et al. Trophectoderm biopsy reduces the level of serum β-human chorionic gonadotropin in early pregnancy. Fertil Steril. 2020;114:801–808.
   PubMed Web of Science ®Google Scholar
• Anckaert E, Schiettecatte J, Sleurs E, et al. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10–14 weeks of gestation. Fertil Steril. 2008;90(4):1206–1210.
   PubMed Web of Science ®Google Scholar
• Bonne S, Sauleau E, Sananes N, et al. Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy. Fertil Steril. 2016;105(2):410–416.
   PubMed Web of Science ®Google Scholar
• Matilainen M, Peuhkurinen S, Laitinen P, et al. In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies . Fertil Steril. 2011;95(1):378–381.
   PubMed Web of Science ®Google Scholar
• Sahraravand M, Laitinen P, Jarvela I, et al. First-trimester maternal serum ADAM12-s and PAPP-A levels are altered in pregnancies conceived after assisted reproduction techniques (ART). Prenat Diagn. 2016;36(2):163–169.
   PubMed Web of Science ®Google Scholar
• Amor DJ, Xu JX, Halliday JL, et al. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod. 2009;24(6):1330–1338.
   PubMed Web of Science ®Google Scholar
• Cavoretto P, Giorgione V, Cipriani S, et al. Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis. Prenat Diagn. 2017;37(6):540–555.
   PubMed Web of Science ®Google Scholar